Switzerland· 48802028
Tora-dol 30 mg, Injektionslösung
A ketorolac product containing ketorolacum trometamolum, registered in Switzerland by Atnahs Pharma Switzerland AG and dispensed under Swissmedic category B. The same ATC class is registered in 9 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Ketorolac is registered in 9 of 19 countries.
Countries holding a registration under ATC M01AB15 (ketorolac), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 6 of them publish a price we can compare per daily dose
Ketorolac · ATC M01AB15
9 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ketorolac costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ketorolac · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- US United States$0.49 (acquisition cost)
The record
At a glance
Swissmedic (Switzerland)- Active substance
- ketorolacum trometamolum
- Manufacturer
- Atnahs Pharma Switzerland AG
- Country
- Switzerland (CH)
- ATC code
- M01AB15
- ATC class
- Ketorolac
- Defined daily dose
- 30 mg, O
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for ketorolac.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ketorolac · interactions on record
378 records
- 69 severe
- 129 moderate
- 5 minor
- 94 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M01AB15
Ketorolac, as other registers publish it.
- CanadaAPO-KETOROLACAPOTEX INC
- ItalyBENKETOLPHARMABER S.R.L.
- NorwayCaloketEQL Pharma AB
- DenmarkCaloketEQL Pharma AB
- FinlandCaloketEQL Pharma AB
- ItalyEUMATEPIFARMA S.R.L.
- CanadaJAMP KETOROLACJAMP PHARMA CORPORATION
- United KingdomKetorolac 30mg/1ml solution for injection ampoulesPeckforton Pharmaceuticals Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab0ffb93-4e84-4f5c-b4e5-188879244bae GET /v1/drugs/ab0ffb93-4e84-4f5c-b4e5-188879244bae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about ketorolac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.